Smith & Nephew

Smith & Nephew is a global medical technology company that designs and manufactures technology for the repair, regeneration and replacement of soft and hard tissue. Founded in 1856, it traces its origins to a small pharmacy in Hull, England. The company employs more than 18,000 people and operates in over 100 countries, serving millions of patients each year. It is listed on the London Stock Exchange, where it is a FTSE 100 constituent, and on the New York Stock Exchange.

The company's work spans orthopaedics, sports medicine, ENT (ear, nose and throat) and advanced wound management. Products include the PICO negative pressure wound therapy system, the CORI Surgical System for robotics-assisted surgery, and the REGENETEN Bioinductive Implant, which supports tissue repair and regeneration. Its technical domains cover medical device design and manufacturing, robotics-assisted surgery, negative pressure wound therapy, bioinductive implant technology and wound management technology.

Smith & Nephew states its mission as restoring "people's bodies and their self-belief by using technology to take the limits off living", with an emphasis on reducing the human and economic cost of wounds and on pushing the boundaries of patient care. The company also sponsors elite athletes, including UFC fighter Tom Aspinall, through injury recovery.